Q3 2016 Holdings
Filed 2016-11-08 | 107 holdings | $629.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Shire Plc | SPONSORED ADR | 82481R106 | $26.6M | 409,858 | 4.2% |
| Eli Lilly & Co(LLY) | COM | 532457108 | $20.5M | 255,000 | 3.3% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $19.8M | 161,702 | 3.1% |
| Celgene Corp(CELG) | COM | 151020104 | $19.4M | 186,000 | 3.1% |
| Pfizer Inc | COM | 717081102 | $18.8M | 555,355 | 3.0% |
| Allergan Plc | SHS | G0177J108 | $18.3M | 79,500 | 2.9% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $18.2M | 130,000 | 2.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $17.8M | 57,000 | 2.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $17.4M | 185,000 | 2.8% |
| Gilead Sciences Inc | COM | 375558102 | $16.4M | 207,304 | 2.6% |
| Medtronic Plc | SHS | G5960L102 | $14.6M | 169,078 | 2.3% |
| Cvs Health Corp(CVS) | COM | 126650100 | $14.2M | 160,000 | 2.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $13.0M | 140,000 | 2.1% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $12.8M | 237,000 | 2.0% |
| Merck & Co. Inc.(MRK) | COM | 58933Y105 | $12.5M | 200,000 | 2.0% |
| Teva Pharmaceutical(TEVA) | SHS | 881624209 | $12.4M | 270,000 | 2.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $11.9M | 29,500 | 1.9% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $11.1M | 85,000 | 1.8% |
| Cigna Corp | COM | 125509109 | $10.9M | 84,000 | 1.7% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $10.9M | 85,000 | 1.7% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $9.2M | 675,000 | 1.5% |
| Amgen Inc(AMGN) | COM | 031162100 | $9.2M | 55,000 | 1.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.8M | 130,000 | 1.4% |
| Anthem Inc | COM | 036752102 | $8.5M | 67,434 | 1.3% |
| Hca Holdings Inc(HCA) | COM | 40412C101 | $8.3M | 110,000 | 1.3% |
| Alkermes Plc(ALKS) | SHS | G01767105 | $8.3M | 175,599 | 1.3% |
| Express Scripts Holding Co | COM | 30219G108 | $7.8M | 111,000 | 1.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $7.7M | 600,000 | 1.2% |
| Jazz Pharmaceuticals Plc(JAZZ) | SHS | G50871105 | $7.3M | 60,000 | 1.2% |
| Endo International Plc | SHS | G30401106 | $7.3M | 360,200 | 1.2% |
| Hologic Inc(HOLX) | COM | 436440101 | $7.0M | 180,000 | 1.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.0M | 80,013 | 1.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.9M | 110,000 | 1.1% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $6.7M | 390,000 | 1.1% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $6.7M | 270,000 | 1.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $6.6M | 55,000 | 1.1% |
| Horizon Pharma Plc | SHS | G4617B105 | $6.6M | 365,000 | 1.1% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $6.3M | 160,000 | 1.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.7M | 65,000 | 0.9% |
| Endologix Inc | COM | 29266S106 | $5.6M | 435,000 | 0.9% |
| Xencor Inc(XNCR) | COM | 98401F105 | $5.5M | 225,000 | 0.9% |
| Centene Corp(CNC) | COM | 15135B101 | $5.4M | 80,000 | 0.9% |
| Lion Biotechnologies Inc | COM | 53619R102 | $5.3M | 650,000 | 0.8% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $5.2M | 65,000 | 0.8% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $5.1M | 49,300 | 0.8% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM | 766559603 | $5.1M | 1,400,000 | 0.8% |
| Kite Pharma Inc | COM | 49803L109 | $5.0M | 90,000 | 0.8% |
| Aetna Inc | COM | 00817Y108 | $4.8M | 42,000 | 0.8% |
| Omnicell Inc(OMCL) | COM | 68213N109 | $4.5M | 118,537 | 0.7% |
| Humana Inc(HUM) | COM | 444859102 | $4.4M | 25,000 | 0.7% |